The Senate health committee will vote Feb. 28 on four bills, including the animal drug and animal generic drug user fee reauthorization bill, which the committee held a hearing on last week. The senate committee will also consider a childhood cancer bill, which would give the National Institutes of Health, Centers for Disease Control and Prevention and HHS additional authority to issue research grants. During the hearing, senators praised FDA’s efforts to slow the spread of antimicrobial resistance by moderating...